This is the first plan I've seen. And to be honest, its decent. Nothing revolutionary, and no way to compare to current management (as they dont publish a plan)

With that said, I would wonder what their plan is with all of the current trials (brazil, Nash, HIV). I certainly hope the plan is to complete them.

I do think there is value in following the H score with respect to cancer targets. I would like to think current management is aware of this as well.

I wish there could be a compromise that protected shareholders, but brought some of Dr P's tools and skills back on board. I know many have disowned him at this point.